TheraVet is a vet biotech company founded in 2017 and headquartered in Belgium, specialized in osteoarticular treatments for small companion animals such as dogs and cats, but also horses. TheraVet’s objective is to develop well-aimed, safe and effective treatments to improve the well-being and quality of life of companion animals suffering from osteoarticular diseases. Our commitment is to meet the needs of innovative and efficient solutions for bone surgeries in cats and dogs as well as horses and for osteoarticular pathologies such as osteoarthritis or ligament injuries. TheraVet works in close collaboration with Key Opinion Leaders in Europe and in the Unites States to better address the ever-increasing needs of veterinary medicine.